As of May 26
| +0.14 / +1.08%|
The 6 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 16.50, with a high estimate of 17.00 and a low estimate of 15.00. The median estimate represents a +25.57% increase from the last price of 13.14.
The current consensus among 7 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.